EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages

Xiaofei Yuan, Xiong Liu, Di Jiang, Zijun Zheng, Xuemin Ma, Shuting Wu, Xiangping Li, Juan Lu, Ming Fu

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-025-04047-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Xiaofei Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. Hauptthemen laut MEDLINE: B7-H1 Antigen, CD8-Positive T-Lymphocytes, Exosomes, Nasopharyngeal Carcinoma. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dongguan Science and Technology of Social Development Program, Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenCD8-Positive T-LymphocytesExosomesNasopharyngeal CarcinomaNasopharyngeal NeoplasmsMacrophagesHumansTumor MicroenvironmentUp-RegulationHypoxia-Inducible Factor 1, alpha SubunitCell Line, TumorMiceAnimalsFemaleMale

Stichwörter der Autor:innen

HypoxiaImmune escapeMacrophageNasopharyngeal carcinomaPD-L1

Substanzen

B7-H1 AntigenCD274 protein, humanHypoxia-Inducible Factor 1, alpha SubunitHIF1A protein, human

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
  • Department of Otolaryngology-Head and Neck Surgery, The First People's Hospital of FoShan, FoShan, 528000, Guangdong, China.
  • Department of Otolaryngology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan People's Hospital), Dongguan, 523000, Guangdong, China.
  • Department of Burns, Nanfang Hospital, Southern Medical University, Jingxi Street, Baiyun District, Guangzhou, 510515, Guangdong, People's Republic of China.
  • Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. li321162@qq.com.
  • Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. lujuanqz@163.com.

Förderung

  • Dongguan Science and Technology of Social Development Program
  • Guangdong Basic and Applied Basic Research Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Yuan, X., Liu, X., Jiang, D., Zheng, Z., Ma, X., Wu, S., Li, X., Lu, J., & Fu, M. (2025). Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04047-7

Vancouver

Yuan X, Liu X, Jiang D, Zheng Z, Ma X, Wu S, et al. Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04047-7

BibTeX
@article{Yuan2025,
  author = {Yuan, Xiaofei and Liu, Xiong and Jiang, Di and Zheng, Zijun and Ma, Xuemin and Wu, Shuting and Li, Xiangping and Lu, Juan and Fu, Ming},
  title = {Exosomal PD-L1 derived from hypoxia nasopharyngeal carcinoma cell exacerbates CD8+ T cell suppression by promoting PD-L1 upregulation in macrophages},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-025-04047-7}
}
Kostenlos starten →